Mangalam Drugs & Organics Limited (BSE: 532637)
Health Care · Pharmaceuticals · IN
Rs27.62
-2.92% today · -65.5% 1Y
Mangalam Drugs & Organics Limited (BSE: 532637) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $4.57M.
Over the last twelve months the share price has lost 65.5%, trading between 22.70 and 85.99.
Tweenvest scores Mangalam Drugs & Organics Limited across four factors: quality 50/100, value 65/100, growth 0/100. Its strongest factor is value.
532637 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $4.57M
- Revenue (TTM)
- $24.54M
- P/E
- —
- EPS
- -24.16
- Dividend yield
- —
- Beta (5Y)
- 0.27
- 52-week high
- Rs85.99
- 52-week low
- Rs22.70
- Avg volume (3M)
- —
- Shares outstanding
- 15.83M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.06T | $1,189.41 | -3.59% |
| Johnson & JohnsonNYSE: JNJ | $650.67B | $270.00 | -1.15% |
| Merck & Co., Inc.NYSE: MRK | $377.72B | $153.10 | -2.14% |
| Roche Holding AGSWX: ROP | $365.10B | CHF368.30 | -1.47% |
| Novartis AGSWX: NOVN | $300.07B | CHF127.18 | -0.90% |
| AstraZeneca PLCLSE: AZN | $257.89B | £122.34 | -1.94% |
| Novo Nordisk A/SCPSE: NOVO B | $210.23B | Dkr304.95 | -0.93% |
| Pfizer Inc.NYSE: PFE | $161.30B | $28.30 | -0.95% |
Figures last refreshed Aug 18, 2026.